loadpatents
name:-0.039910078048706
name:-0.034018039703369
name:-0.00085783004760742
Shankar; Bandarpalle B. Patent Filings

Shankar; Bandarpalle B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shankar; Bandarpalle B..The latest application filed is for "silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases".

Company Profile
0.36.28
  • Shankar; Bandarpalle B. - Branchburg NJ US
  • Shankar; Bandarpalle B. - Neshanic Station NJ US
  • Shankar; Bandarpalle B. - Somerville NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
Grant 9,433,621 - Arasappan , et al. September 6, 2
2016-09-06
Silyl-containing Heterocyclic Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases
App 20150057246 - Dwyer; Michael P. ;   et al.
2015-02-26
Substituted Biphenylene Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases
App 20140377223 - Kozlowski; Joseph A. ;   et al.
2014-12-25
Compounds for the treatment of inflammatory disorders
Grant 8,859,529 - Shankar , et al. October 14, 2
2014-10-14
Compounds for the treatment of inflammatory disorders
Grant 8,569,336 - Tong , et al. October 29, 2
2013-10-29
Compounds for the treatment of inflammatory disorders
Grant 8,541,572 - Kozlowski , et al. September 24, 2
2013-09-24
Compounds for the treatment of inflammatory diseases
Grant 8,450,355 - Wong , et al. May 28, 2
2013-05-28
Compounds For The Treatment Of Inflammatory Disorders
App 20120015926 - Tong; Ling ;   et al.
2012-01-19
Compounds For The Treatment Of Inflammatory Disorders
App 20120010181 - Kozlowski; Joseph A. ;   et al.
2012-01-12
Compounds For The Treatment Of Inflammatory Disorders
App 20110288054 - Shankar; Bandarpalle B. ;   et al.
2011-11-24
Compounds For The Treatment Of Inflammatory Diseases
App 20110288077 - Wong; Michael K.C. ;   et al.
2011-11-24
Compounds for the treatment of inflammatory disorders
Grant 7,879,890 - Yu , et al. February 1, 2
2011-02-01
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity
Grant 7,868,005 - Rosenblum , et al. January 11, 2
2011-01-11
Substituted heterocyclic compounds with CXCR3 antagonist activity
Grant 7,781,437 - Kim , et al. August 24, 2
2010-08-24
Compounds for the treatment of inflammatory disorders
Grant 7,772,263 - Lavey , et al. August 10, 2
2010-08-10
Piperazine-piperidines with CXCR3 antagonist activity
Grant 7,763,616 - Yu , et al. July 27, 2
2010-07-27
Cannabinoid receptor ligands
Grant 7,750,158 - Shankar , et al. July 6, 2
2010-07-06
Cannabinoid receptor ligands
Grant 7,718,702 - Kozlowski , et al. May 18, 2
2010-05-18
Compounds for the treatment of inflammatory disorders
Grant 7,687,527 - Yu , et al. March 30, 2
2010-03-30
Compounds for the treatment of inflammatory disorders
Grant 7,683,085 - Yu , et al. March 23, 2
2010-03-23
Compounds for the treatment of inflammatory disorders
Grant 7,683,088 - Lavey , et al. March 23, 2
2010-03-23
Cannabinoid receptor ligands
Grant 7,645,774 - Friary , et al. January 12, 2
2010-01-12
Cannabinoid receptor ligands
Grant 7,642,272 - Shankar , et al. January 5, 2
2010-01-05
Compounds For The Treatment Of Inflammatory Disorders
App 20090170875 - Yu; Wensheng ;   et al.
2009-07-02
Compounds For The Treatment Of Inflammatory Disorders
App 20090156586 - Lavey; Brian J. ;   et al.
2009-06-18
Compounds For The Treatment Of Inflammatory Disorders
App 20090137586 - Yu; Wensheng ;   et al.
2009-05-28
Compounds for the treatment of inflammatory disorders
Grant 7,524,842 - Lavey , et al. April 28, 2
2009-04-28
Cannabinoid receptor ligands
Grant 7,507,767 - Kozlowski , et al. March 24, 2
2009-03-24
Compounds for the treatment of inflammatory disorders
Grant 7,504,424 - Yu , et al. March 17, 2
2009-03-17
Compounds for the treatment of inflammatory disorders
Grant 7,488,745 - Yu , et al. February 10, 2
2009-02-10
Compounds for the treatment of inflammatory disorders
Grant 7,482,370 - Yu , et al. January 27, 2
2009-01-27
Compounds for the treatment of inflammatory disorders
App 20070265299 - Lavey; Brian J. ;   et al.
2007-11-15
Compounds for the treatment of inflammatory disorders
App 20070219218 - Yu; Wensheng ;   et al.
2007-09-20
Compounds for the treatment of inflammatory disorders
App 20070197564 - Lavey; Brian J. ;   et al.
2007-08-23
Cannabinoid receptor ligands
Grant 7,253,189 - Tong , et al. August 7, 2
2007-08-07
Cannabinoid receptor agonists
Grant 7,217,732 - Kozlowski , et al. May 15, 2
2007-05-15
Substituted heterocyclic compounds with CXCR3 antagonist activity
App 20070082913 - Kim; Seong Heon ;   et al.
2007-04-12
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity
App 20070054919 - Rosenblum; Stuart B. ;   et al.
2007-03-08
Piperazine-piperidines with CXCR3 antagonist activity
App 20060276457 - Yu; Wensheng ;   et al.
2006-12-07
Compounds for the treatment of inflammatory disorders
App 20060276506 - Yu; Wensheng ;   et al.
2006-12-07
Compounds for the treatment of inflammatory disorders
App 20060205797 - Yu; Wensheng ;   et al.
2006-09-14
Cannabinoid receptor ligands
Grant 7,071,213 - Friary , et al. July 4, 2
2006-07-04
Cannabinoid receptor ligands
Grant 7,067,539 - Kozlowski , et al. June 27, 2
2006-06-27
Cannabinoid receptor ligands
App 20060100228 - Shankar; Bandarpalle B. ;   et al.
2006-05-11
Cannabinoid receptor ligands
App 20060009528 - Kozlowski; Joseph A. ;   et al.
2006-01-12
Cannabinoid receptor ligands
App 20050282861 - Friary, Richard J. ;   et al.
2005-12-22
Cannabinoid receptor ligands
App 20040186148 - Shankar, Bandarpalle B. ;   et al.
2004-09-23
Cannabinoid receptor ligands
App 20040132804 - Tong, Ling ;   et al.
2004-07-08
Cannabinoid receptor agonists
App 20040044051 - Kozlowski, Joseph A. ;   et al.
2004-03-04
Cannabinoid receptor ligands
App 20040010013 - Friary, Richard J. ;   et al.
2004-01-15
Cannabinoid receptor ligands
App 20030232859 - Kozlowski, Joseph A. ;   et al.
2003-12-18
Cannabinoid receptor ligands
App 20030096844 - Kozlowski, Joseph A. ;   et al.
2003-05-22
Process for preparing 1-(4-fluorophenyl)-3(R)-(3(S)-hydroxy-3-([phenyl or 4-fluorophenyl])-propyl)-4(S)-(4-hydroxyphenyl)-2-azetidinone
Grant 5,856,473 - Shankar January 5, 1
1999-01-05
Substituted oximes, hydrazones and olefins as neurokinin antagonists
Grant 5,840,725 - Reichard , et al. November 24, 1
1998-11-24
Substituted oximes, hydrazones and olefins as neurokinin antagonists
Grant 5,696,267 - Reichard , et al. December 9, 1
1997-12-09
Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
Grant 5,688,960 - Shankar November 18, 1
1997-11-18
Substituted azetidinone compounds useful as hypocholesterolemic agents
Grant 5,688,990 - Shankar November 18, 1
1997-11-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed